RGS20 and inflammatory bowel disease: Even though there is still a lack of data on the direct assessment of RGS17, RGS19 and RGS20 in IBD and sporadic CRC based on their impact on opioid activity and involvement in processes in other types of cancers, it seems vital to cover this field in the future studies.